Mission
AEC Innovation, a project of the Pharmaceutical Research and Manufacturers of Japan, is a place to discuss and learn about pharmaceutical innovation. We seek to:
- Provide space for an exchange of ideas about pharmaceutical innovation;
- Raise awareness of the critical issues facing pharmaceutical innovation;
- Communicate essential information about the nature of pharmaceutical discovery, the challenges it faces, the value it provides, and the future promise it holds.
In the organizational context, innovation may be linked to changes in efficiency, productivity, quality, competitive positioning, market share, etc. can all be affected positively or negatively by innovative forces. All organizations can innovate, including for example hospitals, universities, and local governments. Some will flourish under its influence. Other will die.
So as innovation typically changes value, innovation may also have a negative or destructive effect as new developments clear away or change old organizational forms and practices. Organizations that do not compensate effectively for innovative forces (mainly from outside) may be destroyed by those that do. Hence managing an organization typically involves risk. A key challenge in management is maintaining a balance between the current processes and business model.
Innovation has been studied in a variety of contexts, including in relation to technology, commerce, social systems, economic development, and policy construction. There are, therefore, naturally a wide range of approaches to conceptualizing innovation in the scholarly literature.[2]
